Altitude Sickness
Information
- Disease name
- Altitude Sickness
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes | Mutation | Description | Source | Links |
---|
NCT ID | Status | Phase | Summary | Start date | Completion date |
---|---|---|---|---|---|
NCT04913389 | Active, not recruiting | Phase 3 | Acetazolamide to Prevent Impending Altitude-illness in Patients With COPD | June 1, 2021 | December 31, 2023 |
NCT01465971 | Completed | Monitoring of the Cerebral Tissue Oxygenation and Perfusion in the Adapting Climber During Sleep in High Altitude | May 2011 | December 2011 | |
NCT02024386 | Completed | Phase 4 | Efficacy Study of Riociguat and Its Effects on Exercise Performance and Pulmonary Artery Pressure at High Altitude | January 2014 | December 2015 |
NCT04075565 | Completed | N/A | The Psychophysiological Effect of Simulated and Terrestrial Altitude | June 24, 2019 | April 30, 2022 |
NCT01171794 | Completed | Phase 3 | Prevention of Altitude Illness With Non-steroidal Anti-inflammatory Study (PAINS) | July 2010 | August 2010 |
NCT04751292 | Completed | HIGH Altitude CArdiovascular REsearch Latin America Population Study | January 26, 2021 | December 30, 2023 | |
NCT02760121 | Completed | Phase 4 | AZ, MZ, and the Pulmonary System Response to Hypoxia | May 2016 | August 2016 |
NCT04915365 | Recruiting | Phase 3 | Effect of Acetazolamide on Right Heart Function at Rest in Lowlanders With COPD Traveling to High Altitude | May 1, 2021 | December 31, 2023 |
NCT02972411 | Unknown status | N/A | Controlled Hyperventilation as Prophylaxis for Acute Mountain Sickness | October 2016 | May 2017 |
NCT02780908 | Unknown status | N/A | Cardio-respiratory Responses During Hypoxic Exercise in Individuals Born Prematurely | April 2016 | December 2018 |
NCT02941510 | Withdrawn | Phase 3 | Inhaled Budesonide for Altitude Illness Prevention | March 6, 2017 | March 6, 2017 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D000532